Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Altamura

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1976
An immunological approach to the treatment of epilepsyC L Cazzullo, A C Altamura, E Smeraldi
Lancet (London, England)|February 10, 1979
Unwanted effects of fluphenazine enanthate and decanoateS H Curry, A C Altamura, S Montgomery
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1990
Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenicsA C Altamura, R Cavallaro, M G Regazzetti
Biopharmaceutics & Drug Disposition|October 1, 1979
Animal model for investigation of fluphenazine kinetics after administration of long-acting estersA C Altamura, R Whelpton, S H Curry
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
Haloperidol plasma 'threshold' levels for relapse prevention in schizophrenia: a study with haloperidol decanoateA C Altamura, G L Tacchini, M Maes
Clinical Pharmacokinetics|March 1, 1994
Clinical pharmacokinetics of fluoxetineA C Altamura, A R Moro, M Percudani
Acta Neurologica|September 1, 1977
[Neurotransmitters and experimental epilepsy. Study of the activity of various enzymes involved in their synthesis in rats with cobalt powder-induced epilepsy]A C Altamura, F Morosini, P L Giordano
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1990
Nimodipine in human alcohol withdrawal syndrome--an open studyA C Altamura, M G Regazzetti, M Porta
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levelsA C Altamura, M C Mauri, G Guercetti
Epidemiology and Psychiatric Sciences|April 21, 2016
Neuroanatomical voxel-based profile of schizophrenia and bipolar disorderE Maggioni, M Bellani, A C Altamura, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1976
An immunological approach to the treatment of epilepsyC L Cazzullo, A C Altamura, E Smeraldi
Lancet (London, England)|February 10, 1979
Unwanted effects of fluphenazine enanthate and decanoateS H Curry, A C Altamura, S Montgomery
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1990
Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenicsA C Altamura, R Cavallaro, M G Regazzetti
Biopharmaceutics & Drug Disposition|October 1, 1979
Animal model for investigation of fluphenazine kinetics after administration of long-acting estersA C Altamura, R Whelpton, S H Curry
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
Haloperidol plasma 'threshold' levels for relapse prevention in schizophrenia: a study with haloperidol decanoateA C Altamura, G L Tacchini, M Maes
Clinical Pharmacokinetics|March 1, 1994
Clinical pharmacokinetics of fluoxetineA C Altamura, A R Moro, M Percudani
Acta Neurologica|September 1, 1977
[Neurotransmitters and experimental epilepsy. Study of the activity of various enzymes involved in their synthesis in rats with cobalt powder-induced epilepsy]A C Altamura, F Morosini, P L Giordano
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1990
Nimodipine in human alcohol withdrawal syndrome--an open studyA C Altamura, M G Regazzetti, M Porta
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levelsA C Altamura, M C Mauri, G Guercetti
Epidemiology and Psychiatric Sciences|April 21, 2016
Neuroanatomical voxel-based profile of schizophrenia and bipolar disorderE Maggioni, M Bellani, A C Altamura, et al.
Pageof 12